Most investors are said to be positioned defensively. “Cash balances for EU funds were historically elevated at the start of ...

The outlook is supported by a “solid 2Q25 Digital ad expert check,” which, TD Cowen analysts note, “showed accelerating spend ...

Morgan Stanley said second-quarter global PC shipments came in stronger than expected but warned that growth is likely to ...

Investing.com -- Tandem Diabetes Care (NASDAQ: TNDM) stock fell 5% Wednesday morning after Citi downgraded the medical device maker to Sell from Neutral, citing intensifying competitive pressures.